Blood test could track brain tumors without surgery
NCT ID NCT05925218
First seen Mar 05, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study aims to develop a simple blood test (liquid biopsy) to monitor high-grade gliomas, an aggressive type of brain tumor. Researchers will collect blood samples from 70 adult patients before and after treatment to see if they can detect tumor DNA and track changes over time. The goal is to find a non-surgical way to follow how the tumor responds to therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Health Network
Toronto, Ontario, L4W4C2, Canada
Conditions
Explore the condition pages connected to this study.